[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ametropia\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ametropia":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,40,64],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100635772","optimization-for-toric-contact-lenses-100635772",false,"NCT07557030","Optimization for Toric Contact Lenses","Inclusion Criteria:\n\n1. They are at least 18 years of age.\n2. They understand their rights as a research participant and are willing and able to sign a Statement of Informed Consent.\n3. They have spherical refractive error at the corneal plane between +4.00 to -7.00DS\n4. They have refractive astigmatism at the corneal plane of 0.75 to 2.25DC in one eye.\n5. They are able to achieve distance HCHL visual acuity of +0.10 logMAR or better in each eye\n6. They are a current soft contact lens wearer or have previous experience of successful soft contact lens wear in the past 3 years.\n\nExclusion Criteria:\n\n1. Is participating in any concurrent clinical or research trial.\n2. They have an ocular disorder which would normally contra-indicate contact lens wear.\n3. They have a systemic disorder which would normally contra-indicate contact lens wear.\n4. They are pseudophakic or aphakic.\n5. They have had corneal refractive surgery.\n6. They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.\n7. Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable.","ALL","18 Years",{"count":18,"type":19},45,"ESTIMATED","INTERVENTIONAL",[22],"NA","The aim of this study is to evaluate the agreement between subjective and objective toric lens prescriptions.",[25,26],"Astigmatism","Ametropia","NOT_YET_RECRUITING","2026-05-04",{"date":30,"type":31},"2026-05-06","ACTUAL",{"date":33,"type":19},"2026-05",{"date":35,"type":19},"2026-08",{"name":37,"class":38},"CooperVision International Limited (CVIL)","INDUSTRY",1,{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":4,"eligibilityCriteria":45,"healthyVolunteers":11,"sex":15,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":4,"studyType":50,"phases":4,"briefSummary":51,"conditions":52,"keywords":4,"overallStatus":54,"whyStopped":4,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":63},"100585455","north-american-comfilcon-a-clinical-study-100585455","NCT06902584","North American Comfilcon A Clinical Study","Inclusion Criteria:\n\n1. Age 8 to 75 years (inclusive).\n2. Current wearer of the Comfilcon A sphere, toric, multifocal, toric multifocal or Energys contact lens for at least 12 months.\n3. At least occasional overnight wear in the last 12 months.\n\nExclusion Criteria:\n\n1\\. Current participation in a contact lens or contact lens care product clinical trial.","8 Years","75 Years",{"count":49,"type":19},182,"OBSERVATIONAL","The main objective of this study is to demonstrate acceptable safety and effectiveness (performance) of comfilcon A Sphere, Toric, Multifocal, Toric Multifocal and Energys lenses, when used in the general population.",[25,53,26],"Presbyopia","RECRUITING","2025-08-25",{"date":57,"type":31},"2025-08-27",{"date":59,"type":31},"2025-02-05",{"date":61,"type":19},"2025-12",{"name":37,"class":38},4,{"id":65,"slug":66,"hasResults":11,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":4,"eligibilityCriteria":70,"healthyVolunteers":71,"sex":15,"minAge":72,"maxAge":46,"enrollmentInfo":73,"targetDuration":4,"studyType":20,"phases":75,"briefSummary":76,"conditions":77,"keywords":4,"overallStatus":54,"whyStopped":4,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":86,"locationsCount":88},"100583905","the-objective-of-this-study-is-to-evaluate-the-perfomance-of-a-photorefraction-device-for-screening-ametropia-in-children-eligible-participants-will-undergo-multiple-refractive-error-measurements-visual-acuity-and-strabismus-assessments-during-a-single-evaluation-visit-100583905","NCT06882408","The Objective of This Study is to Evaluate the Perfomance of a Photorefraction Device for Screening Ametropia in Children. Eligible Participants Will Undergo Multiple Refractive Error Measurements, Visual Acuity and Strabismus Assessments During a Single Evaluation Visit.","Evaluation of the Photorefraction Screener Snapsight in Comparison With Cycloplegia Table-top Autorefractor in Ametropia in Pediatric Population Between 3 and 8yo, Multicenter French Study.","Inclusion Criteria:\n\n* Aged between 3-8 years when included in the study\n* All skin phototypes (I to VI according to the Fitzpatrick classification)\n* Wearing glasses or not\n* Capacity to give valid consent\n* Capacity to follow the protocol to obtain reliable measure\n* Under French medical insurance\n\nExclusion Criteria:\n\n* Under myopia control solution that may have an impact on refractive error (such as: atropine, orthokeratology,..)\n* Wearing contact lenses\n* Ocular or systemic pathology that may have an impact on vision or may interfere with the study measures (except strabismus)\n* Under medication that may have an impact on vision or may interfere with study measurements\n* Known contraindication to the active substance or to one of the excipients of eye drops (Mydriaticum 0.5%, Skiacol 0.5%)\n* Known risk of angle-closure glaucoma\n* Participation to another study that may have an impact on vision or may interfere with the study measures",true,"3 Years",{"count":74,"type":19},315,[22],"The goal of this clinical trial is to evaluate the performance of a photorefraction screener in terms of sensibility, sensitivity and accuracy on children aged 3 to 8 y.o. The main objectives of the study are:\n\n* Evaluate the performances of the device in comparison with the gold standard, i.e. a tabletop refractometer.\n* Assess the agreement of the measures obtained with the device with those obtained with the gold standard.",[26,78,79],"Myopia; Refractive Error","Myopia; Astigmatism","2025-04-28",{"date":82,"type":31},"2025-04-29",{"date":84,"type":19},"2025-04",{"date":61,"type":19},{"name":87,"class":38},"Essilor International",2]